Cost-effectiveness achieved through changing the composition of renal replacement therapy in Japan

JOURNAL ARTICLE published January 2012 in Journal of Medical Economics

Authors: Utako Shimizu | Shota Saito | Yiwei Lings | Noriaki Iino | Junichirou James Kazama | Kohei Akazawa

Evaluating the accessibility of essential medicines in China

JOURNAL ARTICLE published 3 August 2018 in Journal of Medical Economics

Authors: Xiaoyu Xi | Piaopiao Chen | Fan Yang | Yifan Yang | Lili Chen | Ningying Mao

Cost-effectiveness of intravitreal aflibercept versus other treatments for wet age-related macular degeneration in Japan

JOURNAL ARTICLE published 1 February 2017 in Journal of Medical Economics

Authors: Yasuo Yanagi | Aya Fukuda | Victor Barzey | Kenji Adachi

A critical review of the full economic evaluations of pharmacological treatments for glaucoma

JOURNAL ARTICLE published January 2008 in Journal of Medical Economics

Authors: Daniela Koleva | Paola De Compadri | Gianni Virgili | Alessandro Nobili | Livio Garattini

Using a single product (calcipotriene/betamethasone topical suspension) vs multiple products to manage body and scalp psoriasis: comparisons in resource utilization and costs

JOURNAL ARTICLE published December 2013 in Journal of Medical Economics

Authors: Steven R. Feldman | Eugenia Levi | Prathamesh Pathak | Sonali Kakatkar | Rajesh Balkrishnan

Switching of biologic disease modifying anti-rheumatic drugs in patients with rheumatoid arthritis in a real world setting

JOURNAL ARTICLE published April 2014 in Journal of Medical Economics

Authors: Brian Meissner | Digisha Trivedi | Min You | Lisa Rosenblatt

The cost-effectiveness of glasdegib in combination with low-dose cytarabine, for the treatment of newly diagnosed acute myeloid leukemia in adult patients who are not eligible to receive intensive induction chemotherapy in Canada

JOURNAL ARTICLE published 1 January 2021 in Journal of Medical Economics

Authors: Yannan Hu | Majed Charaan | Ilse van Oostrum | Bart Heeg | Timothy Bell

Cost effectiveness of deferasirox compared to desferrioxamine in the treatment of iron overload in lower-risk, transfusion-dependent myelodysplastic syndrome patients

JOURNAL ARTICLE published September 2010 in Journal of Medical Economics

Authors: K. Tolley | N. Oliver | E. Miranda | K. Migliaccio-Walle | D. Bozkaya | Q. Li

Healthcare resource utilization and costs for hip dislocation following primary total hip arthroplasty in the medicare population

JOURNAL ARTICLE published 1 January 2021 in Journal of Medical Economics

Authors: Jack Mantel | Abhishek S. Chitnis | Jill Ruppenkamp | Chantal E. Holy | Juan Daccach

Relationship between incidence of fracture and health-related quality-of-life in metastatic breast cancer patients with bone metastases

JOURNAL ARTICLE published February 2013 in Journal of Medical Economics

Authors: Mark S. Walker | Paul J. E. Miller | Madhav Namjoshi | Arthur C. Houts | Edward J. Stepanski | Lee S. Schwartzberg

Budget impact analysis of adjunctive therapy with lacosamide for partial-onset epileptic seizures in Belgium

JOURNAL ARTICLE published January 2011 in Journal of Medical Economics

Authors: Steven Simoens

Clinical implications and cost-effectiveness analysis of rivaroxaban in patients with coronary artery disease or peripheral arterial disease in the Netherlands

JOURNAL ARTICLE published 1 January 2021 in Journal of Medical Economics

Authors: J. A. Spoorendonk | J.-B. Briere | K. Bowrin | A. Millier | M. Coppens | S. Tempelaar | B. Verheggen

Adherence and outcomes associated with copayment burden in schizophrenia: a cross-sectional survey

JOURNAL ARTICLE published 14 July 2010 in Journal of Medical Economics

Authors: Edward Kim | Shaloo Gupta | Susan Bolge | Chi-Chang Chen | Richard Whitehead | John A. Bates

Benefits of fracture liaison services (FLS) in four Latin American countries: Brazil, Mexico, Colombia, and Argentina

JOURNAL ARTICLE published 1 January 2021 in Journal of Medical Economics

Authors: Rima Aziziyeh | Javier Garcia Perlaza | Najma Saleem | Hannah Guiang | Kirk Szafranski | Rebecca K. McTavish

A comparison of preferences for two GLP-1 products – liraglutide and exenatide – for the treatment of type 2 diabetes

JOURNAL ARTICLE published December 2010 in Journal of Medical Economics

Authors: Michael Polster | Elaine Zanutto | Susan McDonald | Christopher Conner | Mette Hammer

Estimating the rates of disability progression in people with active relapsing-remitting multiple sclerosis

JOURNAL ARTICLE published January 2007 in Journal of Medical Economics

Authors: Ray Gani | Richard M Nixon | Steve Hughes | Chris H Jackson

Healthcare costs in postmenopausal women with hormone-positive metastatic breast cancer

JOURNAL ARTICLE published December 2010 in Journal of Medical Economics

Authors: Maureen J. Lage | Rohit Borker | Beth Barber | Sue Gao

Clinical outcome of hypertension management

JOURNAL ARTICLE published January 2008 in Journal of Medical Economics

Authors: Vivian WY Lee | Tony HW Chan | Tina TL Ko | Kenneth KC Lee | Brian Tomlinson

Healthcare utilization of back pain patients: results of a claims data analysis

JOURNAL ARTICLE published January 2011 in Journal of Medical Economics

Authors: G. Müller-Schwefe | A. Freytag | A. Höer | G. Schiffhorst | A. Becker | H.-R. Casser | G. Glaeske | R. Thoma | R.-D. Treede

Constructing a value-based healthcare system for hypertensive patients through changing payment mode: evidence from a comparative study in rural China

JOURNAL ARTICLE published 4 March 2019 in Journal of Medical Economics

Research funded by National Natural Science Foundation of China (71603132) | China Postdoctoral Science Foundation (2018M63278163) | Guangzhou Science and Technology key Project (201704020208)

Authors: Yudong Miao | Xiangdong Yuan | Jianqin Gu | Liang Zhang | Ruibo He | Sandeep Sandeep | Jian Wu